New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 14, 2012
16:12 EDTBG, SZYMSolazyme announces Joint Venture Expansion Framework with Bunge unit
Solazyme (SZYM) announced that it has entered into a Joint Venture Expansion Framework Agreement with Bunge Global Innovation, a wholly-owned subsidiary of Bunge Limited (BG). The agreement sets forth the intent of the partners to expand joint venture-owned oil production capacity at Solazyme Bunge Renewable Oils from the current 100,000 metric tons under construction in Brazil to 300,000 metric tons by 2016 at select Bunge owned and operated processing facilities worldwide. Also, the companies intend to expand the portfolio of oils to be produced out of their joint venture facility in Brazil. The expanded field and portfolio of oils would include certain tailored food oils for sale in Brazil, where Bunge is the largest supplier of edible oils through several of its retail brands. The parties intend to work together through joint market development to bring new healthy and nutritious edible oils to the Brazilian market. The parties anticipate negotiation of definitive agreements in the coming months.
News For SZYM;BG From The Last 14 Days
Check below for free stories on SZYM;BG the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
May 17, 2013
09:05 EDTSZYMKeating Capital announces exit from Solazyme stake
Keating Capital (KIPO) announced that it sold the remaining 147,927 shares it held in Solazyme (SYZM) during May 2013. The sale generated net proceeds of $1.55M, or $10.51 per share, and a net realized gain of $49,820, or approximately 0.5c for each Keating Capital share outstanding.
May 15, 2013
07:31 EDTBGBMO Capital to host a conference
Subscribe for More Information
May 13, 2013
12:56 EDTSZYMSolazyme May and June volatility elevated on sharp rally
Solazyme May call option implied volatility is at 64, June is at 63, September is at 45, December is at 40; compared to its 26-week average of 46 according to Track Data, suggesting large near term price movement.
May 8, 2013
16:20 EDTSZYMSolazyme reports Q1 adjusted EPS (35c), consensus (43c)
Subscribe for More Information
16:16 EDTSZYMSolazyme, AkzoNobel enter agreement spanning surfactants and coatings market
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.